UNIL-088
| Code | Size | Price |
|---|
| TAR-T34999-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
UNIL088 is a water-soluble prodrug of cyclosporine A (CsA) designed for topical ocular delivery. The pro-moiety is grafted via an ester function to CsA and the solubilizing group is a phosphate ion. UNIL-088 can be rapidly hydrolysed under physiological conditions, and can retain a long shelf-life in aqueous media. UNIL-088 is more stable at pH 5 than at pH 7 with conversion rate constant of 3.2 x 10(-3) and 26.0 x 10(-3)days(-1), respectively.
CAS:
473545-11-8
Formula:
C73H128N13O22P
Molecular Weight:
1570.87
Purity:
0.98
SMILES:
CC[C@@H]1NC(=O)[C@H]([C@H](OC(=O)CN(C)C(=O)[C@H](COP(O)(O)=O)NC(=O)OC(C)OC(C)=O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C
References
Lallemand, F.; Varesio, E.; Felt-Baeyens, O.; Bossy, Leila; Hopfgartner, G.; Gurny, R. Biological conversion of a water-?soluble prodrug of cyclosporine A. European Journal of Pharmaceutics and Biopharmaceutics (2007), 67(2), 555-561.
Lallemand, F.; Behar-Cohen, F.; Felt-Baeyens, O.; Rudaz, S.; Furrer, P.; Besseghir, K.; Dumont, J.-M.; Gurny, R. Cyclosporine A prodrug for topical delivery to the eye. Ocular Pharmacology and Therapeutics--ISOPT, Proceedings of the International Symposium, 5th, Monte Carlo, Monaco, Mar. 11-14, 2004 (2004), 105-109.
Lallemand, Frederic; Perottet, Philippe; Felt-Baeyens, Olivia; Kloeti, Werner; Philippoz, Florence; Marfurt, Judith; Besseghir, Kamel; Gurny, RobertA water-?soluble prodrug of cyclosporine A for ocular application: A stability study. European Journal of Pharmaceutical Sciences (2005), 26(1), 124-129.
Lallemand, F.; Furrer, P.; Felt-Baeyens, O.; Gex-Fabry, M.; Dumont, J.-M.; Besseghir, K.; Gurny, R. A novel water-?soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics. International Journal of Pharmaceutics (2005), 295(1-2), 7-14.